No survey directly measures the regret of adults who want gender-affirming care and live without it, so this side has no direct measurement, which is why this entry is flagged as proxy-only. The evidence is indirect. Turban et al.’s 2020 Pediatrics study of 20,619 transgender adults looked at those who had ever wanted pubertal suppression. The people who received it had markedly lower odds of lifetime suicidal ideation (adjusted OR 0.3) than those who wanted it but could not access it. The 2022 U.S. Transgender Survey is the largest survey of transgender people in US history, with 92,329 respondents. Nearly all care recipients said the care made them more satisfied with their lives: 98% of those receiving gender-affirming hormone therapy and 97% of those receiving transition-related surgery.
Bustos et al.’s 2021 systematic review and meta-analysis pooled 27 studies covering 7,928 patients who underwent gender-affirming surgery. The pooled regret prevalence was 1% (95% CI <1%–2%). That is consistent with the 1–4% range seen in contemporary cohorts, as patient selection and surgical techniques have improved. Regret after hormonal treatment alone is lower than after surgery. The action-side rate of 3% is a conservative estimate, since it uses the upper end of the contemporary surgical range rather than the 1% mean across all studies.
The clinical evidence on outcomes is now extensive and consistent. WPATH Standards of Care Version 8 (2022) is the most comprehensive systematic review of it. It confirms that gender-affirming medical and surgical interventions are associated with significant reductions in gender dysphoria, depression, anxiety and suicidality in transgender and gender diverse adults. Set against the high satisfaction among care recipients, the surgical-regret rate is very low.
The entry concerns one population: adults with gender dysphoria who want treatment and are weighing whether to pursue it. For them the evidence consistently shows rare regret after care. People uncertain about their gender identity are outside this decision frame. Their question is different, and the evidence base for it is sparser. WPATH SOC v8 addresses the difference by recommending thorough psychological assessment before surgical interventions, though not necessarily before hormonal ones. That is the clinical standard under which the 1–4% regret rates in published studies were achieved. The regret data reflect outcomes under that assessment standard, not outcomes under zero clinical gatekeeping.







